Betacetylmethadol
Synthetic opioid drug
- None
- AU: S9 (Prohibited substance)
- BR: Class A1 (Narcotic drugs)[1]
- CA: Schedule I
- DE: Anlage I (Authorized scientific use only)
- US: Schedule I
- (3S,6R)-6-(dimethylamino)-4,4-diphenyl-3-heptanyl acetate
- 17199-59-6
- 62710
- DB01522
- 56457
- 905GLN509G
- D12661
- ChEMBL2105619
- DTXSID30169199
- Interactive image
- O=C(O[C@H](C(c1ccccc1)(c2ccccc2)C[C@H](N(C)C)C)CC)C
InChI
- InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22+/m1/s1
- Key:XBMIVRRWGCYBTQ-GCJKJVERSA-N
Betacetylmethadol is a synthetic opioid.[2] It is a diastereoisomer of alphacetylmethadol (as well as levacetylmethadol).[2] In the United States, betacetylmethadol is a Schedule I drug Narcotic under the Controlled Substances Act,[3] with an ACSCN of 9607 and a 2 gramme manufacturing quota as of 2014.[citation needed]
See also
References
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ a b Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology. 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424. S2CID 19815273.
- ^ 21 U.S.C. § 812(b)(1)
- v
- t
- e
modulators
Calcium blockers |
|
---|---|
Sodium blockers |
|
Potassium openers |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e